To address these concerns, in this study, we have used functional approaches, together with MHC class II/ESO peptide tetramers to assess ESO-specific cells among conventional and Treg CD4+ T-cell subsets in circulating lymphocytes of epithelial ovarian cancer (EOC) patients with detectable spontaneous immune responses to ESO. Here, CD4 is linked to ovarian carcinoma.